Philadelphia Trust Company’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-7,976
Closed -$296K – 202
2019
Q1
$296K Buy
+7,976
New +$290K 0.03% 181
2018
Q4
– Sell
-7,976
Closed -$315K – 182
2018
Q3
$315K Hold
7,976
– – 0.03% 174
2018
Q2
$354K Sell
7,976
-2,290
-22% -$114K 0.03% 167
2018
Q1
$500K Sell
10,266
-800
-7% -$40K 0.04% 153
2017
Q4
$554K Sell
11,066
-490
-4% -$25.7K 0.04% 151
2017
Q3
$585K Sell
11,556
-1,000
-8% -$47.2K 0.05% 142
2017
Q2
$476K Sell
12,556
-279
-2% -$11K 0.04% 151
2017
Q1
$494K Buy
12,835
+217
+2% +$6.53K 0.04% 158
2016
Q4
$279K Sell
12,618
-82
-0.6% -$1.68K 0.02% 193
2016
Q3
$203K Sell
12,700
-1,363
-10% -$15.6K 0.02% 194
2016
Q2
$116K Sell
14,063
-600
-4% -$5.35K 0.01% 183
2016
Q1
$103K Sell
14,663
-26,690
-65% -$134K 0.01% 178
2015
Q4
$226K Sell
41,353
-6,737
-14% -$43.1K 0.02% 172
2015
Q3
$311K Buy
+48,090
New +$503K 0.03% 147

Other funds holding CC

Philadelphia Trust Company's CC Position: Q2 2019 in Review

Philadelphia Trust Company sold out of Chemours (CC) in Q2 2019, closing a stake of 7,976 shares — an estimated $296K sold.

Philadelphia Trust Company first reported a position in CC in Q3 2015 and held it in 14 quarters. The position peaked at $585K in Q3 2017. 488 funds tracked by Wall St. Rank hold CC as of Q2 2019.

  • Philadelphia Trust Company reported no remaining Chemours position as of Q2 2019 after selling out during the quarter.
  • Philadelphia Trust Company sold 7,976 Chemours shares in Q2 2019, an estimated $296K.
  • Philadelphia Trust Company first reported a position in Chemours in Q3 2015 and held it in 14 quarters.
  • Philadelphia Trust Company's Chemours position peaked at $585K in Q3 2017.
  • 488 funds tracked by Wall St. Rank held Chemours as of Q2 2019.

Based on Philadelphia Trust Company's 13F filing for Q2 2019, filed 8 Aug 2019.